More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-6 of 6 results

  • ringtx.com
  • 1
  • 1
  • 18
Ring Therapeutics is creating anellovirus vectors that can safely and effectively deliver therapies for diverse modalities to target cells and tissues... Ring's research team has uncovered the world's largest collection of commensal anelloviruses..
Relevance: 12.935161
  • www.repertoire.com
  • 3
  • 1
  • 25
Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease... We are developing..
Relevance: 9.989178
  • www.ionispharma.com
  • 2
  • 6
  • 48
Akcea is a wholly owned subsidiary of Ionis. Akcea commercializes TEGSEDI™ (inotersen) and WAYLIVRA® (volanesorsen), and with Ionis, is advancing a mature pipeline of novel medicines discovered by Ionis and based on Ionis' proprietary antisense..
Relevance: 5.932687
  • cytokinetics.com
  • 5
  • 4
  • 56
Cytokinetics is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle..
Relevance: 5.8012915
  • www.ionispharma.com
  • 7
  • 6
  • 64
As the leader in RNA-targeted therapeutics for more than three decades, Ionis has focused every moment on advancing drug discovery, development, and providing hope for patients. Our broadly applicable, versatile, and rapidly advancing technology..
Relevance: 5.2492523
  • www.ionispharma.com
  • 7
  • 6
  • 62
As the leader in RNA-targeted therapeutics for more than three decades, Ionis has focused every moment on advancing drug discovery, development, and providing hope for patients. Our broadly applicable, versatile, and rapidly advancing technology..
Relevance: 5.2492523